CEL-SCI and Saudi Amarox to Habits Signing Rite at BIO 2026 for Strategic Settlement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
Saudi Arabia Emerges as a International Biotech Funding Hub Underneath Imaginative and prescient 2030 Senior Saudi Executive, Funding and Healthcare Leaders to Attend the CEL-SCI / Amarox Signing & Opening Ceremonies Strategic Settlement Marks Vital Step Towards Commercialization of Multikine ® in One of the crucial Center East’s Quickest-Rising Healthcare Markets CEL-SCI Company (NYSE American: […]




